Want to see ACRS full AI Analyst Report?
Aclaris Therapeutics (ACRS) Income Statement
Aclaris Therapeutics Income Statement
Last quarter (Q2 2026), Aclaris Therapeutics's total revenue was $1.63M, a decrease of 8.33% from the same quarter last year. In Q2, Aclaris Therapeutics's net income was $-21.50M. See Aclaris Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 7.83M | $ 18.72M | $ 31.25M | $ 29.75M | $ 6.76M | |
| $ 5.74M | $ 15.93M | $ 13.17M | $ 17.79M | $ 2.05M | |
| $ 82.11M | $ 157.86M | $ 110.53M | $ 107.65M | $ 91.77M | |
| Depreciation and Amortization | $ 454.00K | $ 807.00K | $ 863.00K | $ 797.00K | $ 923.00K |
| $ -64.47M | $ -51.72M | $ -115.45M | $ -84.36M | $ -64.46M | |
| $ -76.38M | $ -141.93M | $ -97.36M | $ -89.85M | $ -89.72M | |
| $ 11.45M | $ 9.87M | $ 8.51M | $ 2.95M | $ -1.14M | |
| $ -64.92M | $ -132.06M | $ -88.85M | $ -86.91M | $ -90.86M | |
| $ -64.92M | $ -132.06M | $ -88.48M | $ -86.91M | $ -90.86M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.53 | $ -1.71 | $ -1.27 | $ -1.33 | $ -1.60 |
| Diluted EPS | $ -0.53 | $ -1.71 | $ -1.27 | $ -1.33 | $ -1.60 |
| Weighted Average Shares Outstanding | 122.66M | 77.30M | 69.81M | 65.21M | 56.73M |
| Weighted Average Shares Outstanding (Diluted) | 122.66M | 77.30M | 69.81M | 65.21M | 56.73M |
Currency in USD
